1. |
Kwee RM, Kwee TC. Predicting lymph node status in early gastric cancer. Gastric Cancer, 2008, 11(3): 134-148.
|
2. |
Li C, Kim S, Lai JF, et al. Solitary lymph node metastasis in gastric cancer. J Gastrointest Surg, 2008, 12(3): 550-554.
|
3. |
Huang JY, Xu YY, Li M, et al. The prognostic impact of occult lymph node metastasis in node-negative gastric cancer: a systematic review and meta-analysis. Ann Surg Oncol, 2013, 20(12): 3927-3934.
|
4. |
Yanagita S, Natsugoe S, Uenosono Y, et al. Detection of micrometastases in sentinel node navigation surgery for gastric cancer. Surg Oncol, 2008, 17(3): 203-210.
|
5. |
Shimizu Y, Takeuchi H, Sakakura Y, et al. Molecular detection of sentinel node micrometastases in patients with clinical N0 gastric carcinoma with real-time multiplex reverse transcription-polymerase chain reaction assay. Ann Surg Oncol, 2012, 19(2): 469-477.
|
6. |
Tsirlis TD, Kostakis A, Papastratis G, et al. Predictive significance of preoperative serum VEGF-C and VEGF-D, independently and combined with Ca19-9, for the presence of malignancy and lymph node metastasis in patients with gastric cancer. J Surg Oncol, 2010, 102(6): 699-703.
|
7. |
程鹏. 胃癌诊断中肿瘤标志物 CEA、CA19-9、CA125 的水平变化及临床意义. 中国老年学杂志, 2014, 32(20): 5679-5681.
|
8. |
Jagric T, Potrc S, Ivanecz A, et al. Evaluation of focused sentinel lymph node RT-qPCR screening for micrometastases with the use of the Maruyama computer program. Eur Surg, 2013, 45(5): 270-276.
|
9. |
Jagrič T, Plankl M, Ivanecz A, et al. The prognostic value of micrometastases found intraoperatively in the first drainig lymph node in gastric cancer patients. Zdravniški Vestnik, 2012, 81(11):775-783.
|
10. |
Ishigami S, Natsugoe S, Tokuda K, et al. Clinical impact of micrometastasis of the lymph node in gastric cancer. Am Surg, 2003, 69(7): 573-577.
|
11. |
邓靖宇, 梁寒. 再谈淋巴结转移对胃癌预后评估的意义. 中华胃肠外科杂志, 2016, 19(2): 157-164.
|
12. |
Lee CM, Park SS, Kim JH. Current status and scope of lymph node micrometastasis in gastric cancer. J Gastric Cancer, 2015, 15(1): 1-9.
|
13. |
Sonoda H, Tani T. Clinical significance of molecular diagnosis for gastric cancer lymph node micrometastasis. World J Gastroenterol, 2014, 20(38): 13728-13733.
|
14. |
Dilege E, Mihmanli M, Demir U, et al. Prognostic value of preoperative CEA and CA 19-9 levels in resectable gastric cancer. Hepatogastroenterology, 2010, 57(99-100): 674-677.
|
15. |
张俊, 王永斌, 彭海林, 等. 血清胃蛋白酶原和 CEA 及 CA199 与 CA724 联合检测对胃癌诊断价值研究. 中华肿瘤防治杂志, 2015, 22(B22): 176-178.
|
16. |
陈静, 张德巍, 张春东, 等. 术前血清 CEA、 CA19-9 水平检测对胃癌术后复发转移及预后的意义. 中国普外基础与临床杂志, 2015, 22(2): 195-199.
|
17. |
Kannagi R. Carbohydrate antigen sialyl Lewis a--its pathophysiological significance and induction mechanism in cancer progression. Chang Gung Med J, 2007, 30(3): 189-209.
|
18. |
周粼, 王欢, 梁道明, 等. 血清肿瘤标志物在胃癌术前评估的作用. 中国普外基础与临床杂志, 2016, 23(4): 425-428.
|
19. |
Li F, Li S, Wei L, et al. The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment. Biomarkers, 2013, 18(7): 632-637.
|
20. |
Chou HH, Kuo CJ, Hsu JT, et al. Clinicopathologic study of node-negative advanced gastric cancer and analysis of factors predicting its recurrence and prognosis. Am J Surg, 2013, 205(6): 623-630.
|
21. |
Cao L, Hu X, Zhang Y, et al. Adverse prognosis of clustered-cell versus single-cell micrometastases in pN0 early gastric cancer. J Surg Oncol, 2011, 103(1): 53-56.
|
22. |
吕成余, 谢洪虎, 王蓓, 等. 实时荧光定量 PCR 检测胃癌淋巴结微转移及其临床意义. 中国普外基础与临床杂志, 2012, 19(1): 31-36.
|
23. |
张树朋, 梁寒, 邓靖宇. 术前血清 CA19-9 水平对胃癌患者生存预后的影响. 中国肿瘤临床, 2014, 41(11): 702-706.
|
24. |
杨小波, 邹亮. 肿瘤标志物在胃癌治疗及预后判断应用中的研究进展. 中国普通外科杂志, 2013, 22(10): 1334-1337.
|
25. |
Mihmanli M, Dilege E, Demir U, et al. The use of tumor markers as predictors of prognosis in gastric cancer. Hepatogastroenterology, 2004, 51(59): 1544-1547.
|